No Data
Express News | Molina Healthcare Inc : Stephens Cuts Target Price to $320 From $355
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Barclays Maintains Molina Healthcare(MOH.US) With Hold Rating, Cuts Target Price to $359
Barclays analyst Andrew Mok CFA maintains $Molina Healthcare(MOH.US)$ with a hold rating, and adjusts the target price from $430 to $359.According to TipRanks data, the analyst has a success rate of 4
Stephens Adjusts Price Target on Molina Healthcare to $320 From $355
Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?
Barclays Adjusts Price Target on Molina Healthcare to $359 From $430, Maintains Equalweight Rating